According to the latest data from the Hong Kong Stock Exchange, on January 22, Norges Bank increased its holdings in PHARMARON (03759) by 10.25 million shares, with a transaction price of HK$22.82 per share, amounting to a total consideration of approximately HK$234 million.
Following this acquisition, its latest shareholding quantity stands at approximately 21.4742 million shares, representing a holding ratio of 6.09%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments